Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Burger
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
632 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Tohoku University School of Medicine
Sendai, Aoba-ku, Japan
- Kure National Hospital
Kure, Hiroshima, Japan
- Iwate Medical University School of Medicine
Morioka, Iwate, Japan
- Kagoshima City Hospital
Kagoshima, Kagoshima-ken, Japan
- Keio University
Shinjuku-ku, Tokyo, Japan
- National Hospital Organization-Kobe Medical Center
Kobe, Japan
- Shikoku Cancer Center
Matsuyama, Japan
- Saitama Medical University International Medical Center
Saitama, Japan
- National Cancer Center Hospital
Tokyo, Japan
- Tottori University
Tottori, Japan
- Samsung Medical Center
Seoul, Korea, South Korea
- Asan Medical Center
Seoul, South Korea
- Korea Cancer Center Hospital
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Yongdong Severence Hospital
Seoul, South Korea
- Ajou University Hospital
Suwon, South Korea
- Kangnam Sacred Heart Hospital
Youngdungpo-gu, South Korea
- Northeast Alabama Regional Medical Center
Anniston, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Clearview Cancer Institute
Huntsville, Alabama, United States
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Banner Thunderbird Medical Center
Glendale, Arizona, United States
- Banner Baywood Medical Center
Mesa, Arizona, United States
- Banner Desert Medical Center
Mesa, Arizona, United States
- Banner Good Samaritan Medical Center
Phoenix, Arizona, United States
- Western Regional Ccop
Phoenix, Arizona, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Highlands Oncology Group Pa - Fayetteville
Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville
Fayetteville, Arkansas, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Northbay Cancer Center
Fairfield, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2005
- Primary completion
- 30 Nov 2010
- Completion
- 30 Apr 2015
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 1,873
- Registry id
- NCT00262847
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.